Ashutosh J. Barve

Ashutosh J. Barve

Gastroenterology
401 East Chestnut Street
U Of L Health Care Outpatient Center, Unit 310
Louisville, KY 40202

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

Association of Hypomagnesemia and Liver Injury, Role of Gut-Barrier Dysfunction and Inflammation: Efficacy of Abstinence, and 2-Week Medical Management in Alcohol Use Disorder Patients.

Association of Hypomagnesemia and Liver Injury, Role of Gut-Barrier Dysfunction and Inflammation: Efficacy of Abstinence, and 2-Week Medical Management in Alcohol Use Disorder Patients.

Journal: International journal of molecular sciences
Published: May 16, 2022

Drug Use Evaluation of Direct Oral Anticoagulants (DOACs) in Patients With Advanced Cirrhosis.

Drug Use Evaluation of Direct Oral Anticoagulants (DOACs) in Patients With Advanced Cirrhosis.

Journal: Cureus
Published: April 10, 2022

Theragnostic Efficacy of K18 Response in Alcohol Use Disorder with Clinically Significant Fibrosis Using Gut-Liver Axis.

Theragnostic Efficacy of K18 Response in Alcohol Use Disorder with Clinically Significant Fibrosis Using Gut-Liver Axis.

Journal: International journal of molecular sciences
Published: March 23, 2022

Discovery of Anti-PD-L1 Human Domain Antibodies for Cancer Immunotherapy.

Discovery of Anti-PD-L1 Human Domain Antibodies for Cancer Immunotherapy.

Journal: Frontiers in immunology
Published: December 18, 2021

An Unusual Case of Hemolytic Anemia Reversed with Liver Transplantation.

An Unusual Case of Hemolytic Anemia Reversed with Liver Transplantation.

Journal: International journal of hematology-oncology and stem cell research
Published: June 26, 2021

Enzyme-responsive polymeric micelles of cabazitaxel for prostate cancer targeted therapy.

Enzyme-responsive polymeric micelles of cabazitaxel for prostate cancer targeted therapy.

Journal: Acta biomaterialia
Published: March 24, 2020

Targeted Delivery of an siRNA/PNA Hybrid Nanocomplex Reverses Carbon Tetrachloride-Induced Liver Fibrosis.

Targeted Delivery of an siRNA/PNA Hybrid Nanocomplex Reverses Carbon Tetrachloride-Induced Liver Fibrosis.

Journal: Advanced therapeutics
Published: August 01, 2019

Discovery of low-molecular weight anti-PD-L1 peptides for cancer immunotherapy.

Discovery of low-molecular weight anti-PD-L1 peptides for cancer immunotherapy.

Journal: Journal for immunotherapy of cancer
Published: March 06, 2019

Development of a Biocompatible Copolymer Nanocomplex to Deliver VEGF siRNA for Triple Negative Breast Cancer.

Development of a Biocompatible Copolymer Nanocomplex to Deliver VEGF siRNA for Triple Negative Breast Cancer.

Journal: Theranostics
Published: February 21, 2019

Transarterial chemoembolization in a patient with severe reactions to iodinated contrast: Successful treatment using gadolinium contrast with C-arm computed tomography.

Transarterial chemoembolization in a patient with severe reactions to iodinated contrast: Successful treatment using gadolinium contrast with C-arm computed tomography.

Journal: Radiology case reports
Published: October 01, 2018

Silencing of α-complex protein-2 reverses alcohol- and cytokine-induced fibrogenesis in hepatic stellate cells.

Silencing of α-complex protein-2 reverses alcohol- and cytokine-induced fibrogenesis in hepatic stellate cells.

Journal: Liver research (Beijing, China)
Published: October 03, 2017

Comparison of Avidin, Neutravidin, and Streptavidin as Nanocarriers for Efficient siRNA Delivery.

Comparison of Avidin, Neutravidin, and Streptavidin as Nanocarriers for Efficient siRNA Delivery.

Journal: Molecular pharmaceutics
Published: December 28, 2016
Showing 1-12 of 18

Last Updated: 09/26/2026